Guidelines for Ordering and Interpreting Morning Serum Cortisol

1. Indications for Morning Cortisol Measurement

• Order a morning serum cortisol (8–9 AM) to assess hypothalamic‑pituitary‑adrenal (HPA) axis recovery in patients who have tapered glucocorticoids to physiologic replacement doses (e.g., prednisone 4–6 mg daily) or when clinical suspicion of adrenal insufficiency exists. 1
• Perform the test when the patient has reached a physiologic daily dose equivalent (prednisone 4–6 mg or hydrocortisone 15–25 mg) and plans to discontinue therapy. 2
• Use the measurement to obtain biochemical confirmation of HPA‑axis recovery before stopping glucocorticoids. 3
• Ensure the glucocorticoid dose has been held for ≥ 24 hours (long‑acting agents such as dexamethasone require a longer wash‑out). 4

2. Situations in Which Testing Should NOT Be Performed

• Patients still receiving supraphysiologic glucocorticoid doses. 5
• Patients who require ongoing glucocorticoid therapy for their underlying disease. 6
• Patients on short‑term (≤ 3 weeks) low‑dose glucocorticoid courses. 1

3. High‑Risk Scenarios Warranting a Low Threshold for Testing

• Presence of adrenal‑insufficiency signs/symptoms together with any of the following:
  
  • Current or recent non‑oral glucocorticoid formulations (inhaled, topical, intra‑articular). 5
  • Use of multiple glucocorticoid formulations simultaneously. 2
  • High‑dose inhaled or topical glucocorticoids, or use of these routes for > 1 year. 5
  • Intra‑articular glucocorticoid injection within the past 2 months. 3
  • Concomitant strong CYP3A4 inhibitors. 5
  • Clinical features of exogenous Cushing syndrome (assume adrenal insufficiency without testing). 6

4. Interpretation of Morning Cortisol in Glucocorticoid‑Induced Adrenal Insufficiency

Note: Values near 300 nmol/L may still be insufficient during major stress (sepsis, trauma, surgery); clinical judgment and stress‑dose coverage are advised. 3

5. Primary Adrenal Insufficiency Screening

• Morning cortisol > 18 µg/dL (≈ 500 nmol/L) makes adrenal insufficiency unlikely. 7
• Morning cortisol < 5 µg/dL (≈ 138 nmol/L) makes adrenal insufficiency very likely. 7
• Values 5–18 µg/dL require dynamic testing for definitive diagnosis. 7
• Simultaneous plasma ACTH measurement is essential to differentiate primary from secondary causes. 7

6. Technical Considerations for Accurate Measurement

• Collect the sample between 8:00 AM and 9:00 AM to capture the physiological peak. 3
• Hold the glucocorticoid dose for at least 24 hours before sampling (long‑acting agents should be switched to shorter‑acting agents beforehand). 4
• Switch long‑acting glucocorticoids (e.g., dexamethasone, betamethasone) to shorter‑acting agents (hydrocortisone, prednisone) prior to testing. 6

Factors That May Produce Misleading Total Cortisol Results

7. Role of Dynamic (ACTH Stimulation) Testing

• Routine ACTH stimulation testing is not recommended for patients tapering or stopping glucocorticoids. 8
• Consider ACTH testing only when:
  
  • Repeated morning cortisol remains in the indeterminate range (150–300 nmol/L).
  • Primary adrenal insufficiency is suspected and requires confirmatory testing. 7
  • Recent (< 4 weeks) ACTH deficiency after pituitary surgery or trauma (risk of false‑normal results). 7
  • Partial ACTH deficiency is suspected despite a normal Synacthen test. 7

Standard ACTH stimulation protocol: 250 µg synthetic ACTH (cosyntropin) IV or IM; cortisol measured at baseline and 30 minutes. A peak > 500 nmol/L (≈ 18 µg/dL) indicates adequate adrenal reserve, though assay‑specific cutoffs (≈ 414 nmol/L) may be used. 7

8. Common Pitfalls and Clinical Pearls

• Do not test while the patient is on supraphysiologic glucocorticoid doses – the result is non‑informative. 6
• Recognize that biochemical adrenal insufficiency after taper is common, but clinically significant adrenal crisis is rare; always interpret results in the clinical context. 3
• Provide stress‑dose glucocorticoid coverage for patients with recent or ongoing glucocorticoid exposure who have not been tested, especially during illness, surgery, or trauma. 1

9. Indications for Endocrinology Referral

• Failure to recover HPA‑axis function after ≥ 1 year on physiologic replacement doses. 2
• Occurrence of adrenal crisis while on or after discontinuation of glucocorticoids. 2
• Complex or atypical cases requiring specialized management. 7

Guidelines for Measuring Cortisol in Assessment of Adrenal Function

Timing and Sample Collection

• Collect serum cortisol between 08:00 – 09:00 h, the time of the physiological peak, for primary screening of adrenal insufficiency. 9

Laboratory Measurement Techniques

• Liquid chromatography‑tandem mass spectrometry (LC‑MS/MS) is the gold‑standard assay for serum cortisol because of its highest analytical accuracy. 10
• Immunoassays that use monoclonal antibodies provide intermediate accuracy, while those using polyclonal antibodies are the least accurate. 10
• Reported cut‑off values that exclude adrenal insufficiency vary widely among immunoassays (approximately 336 – 506 nmol/L, 12.2 – 18.3 µg/dL); therefore each laboratory’s reference range must be applied. 9
• Laboratories must supply assay‑specific reference ranges; generic thresholds should not be used. 11

Interpretation Thresholds for Morning Serum Cortisol

Glucocorticoid‑Induced Adrenal Insufficiency

• <150 nmol/L (<5 µg/dL) – strongly suggests persistent adrenal insufficiency; continue glucocorticoid replacement and repeat testing periodically. 12
• 150 – 300 nmol/L (5 – 10 µg/dL) – indeterminate zone; consider dynamic (corticotropin) testing if values remain in this range on repeat. 9
• >300 nmol/L (>10 µg/dL) – indicates likely recovery of the hypothalamic‑pituitary‑adrenal (HPA) axis. 11
• ≥354 nmol/L (≥12.8 µg/dL) – predicts normal adrenal function with 100 % sensitivity. 9

Primary Adrenal Insufficiency

• <140 nmol/L (<5 µg/dL) together with plasma ACTH >2‑fold the upper limit of normal is highly predictive of primary adrenal insufficiency. 13
• Confirmation with a corticotropin stimulation test is recommended unless the result is unequivocally diagnostic. 13

Factors That May Alter Cortisol Measurements

Conditions Leading to Falsely Low Total Cortisol

• Hypoalbuminemia (e.g., due to liver disease, nephrotic syndrome, malnutrition). 9
• Prolonged critical illness. 10
• Disrupted circadian rhythm (e.g., night‑shift work, jet lag, severe insomnia). 10

Conditions Leading to Falsely Elevated Total Cortisol

• Use of oral estrogen preparations (including combined oral contraceptives). 14

*In the presence of these confounders, measurement of free cortisol (serum or salivary) is advisable. 9

Alternative Measurement Methods

• Salivary cortisol reflects the free, biologically active fraction and is not affected by binding‑protein abnormalities; it is a promising ambulatory screening tool, though not yet widely available. 10
• Free serum cortisol is the most reliable approach in critically ill or hypoproteinemic patients. 9

Dynamic (Corticotropin Stimulation) Testing

• Routine dynamic testing is not recommended for patients tapering glucocorticoids. 10

Indications for Performing a Corticotropin Stimulation Test

• Persistent morning cortisol values in the indeterminate range (150 – 300 nmol/L) despite repeat measurements. 12
• Suspected primary adrenal insufficiency that requires confirmatory testing. 13
• Equivocal morning cortisol results when a definitive clinical decision is needed. 13

Standard High‑Dose Test Protocol

Complementary Hormonal Measurements

• Plasma ACTH should be drawn simultaneously with the baseline morning cortisol to differentiate primary from secondary adrenal insufficiency. 15
• ACTH > 66 pmol/L (>300 ng/L) provides maximal adrenal stimulation. 15

• ACTH > 2‑fold the upper limit of normal together with low cortisol confirms primary adrenal insufficiency. 15

• Dehydroepiandrosterone sulfate (DHEAS): Low age‑ and sex‑adjusted DHEAS can be an early clue to primary adrenal insufficiency but is not diagnostic on its own. 13
• DHEAS is not recommended for monitoring recovery from glucocorticoid‑induced adrenal insufficiency because cortisol levels normalize before DHEAS. 10

Serum Cortisol Testing in Patients Tapering Glucocorticoids

1. When to Perform Morning Serum Cortisol

• Measure a morning serum cortisol (8:00‑9:00 AM) in patients who have tapered long‑term glucocorticoid therapy to physiologic replacement doses (e.g., prednisone 4‑6 mg or hydrocortisone 15‑25 mg daily) and are planning to stop treatment; the glucocorticoid dose should be held for ≥24 h before sampling【16】【17】.

• The physiologic dose is low enough that hypothalamic‑pituitary‑adrenal (HPA) axis recovery is possible【16】【17】.

• Testing at higher glucocorticoid doses yields non‑informative results【16】【17】【18】.

• Patients must withhold glucocorticoids for at least 24 h before the test (longer washout required for dexamethasone)【19】【20】.

2. Situations in Which Cortisol Testing Should NOT Be Performed

• Patients still receiving supraphysiologic glucocorticoid doses【16】【17】【18】.
• Patients who require ongoing glucocorticoid therapy for their underlying disease【16】【17】【18】.
• Patients on short‑term glucocorticoid courses (< 3‑4 weeks); HPA suppression is unlikely and therapy can be stopped abruptly【16】【17】【18】.

3. High‑Risk Scenarios Warranting a Lower Threshold for Testing

• Presence of signs or symptoms of adrenal insufficiency together with any of the following:

4. Evaluation of Suspected Primary Adrenal Insufficiency

• Order a morning cortisol in acutely ill patients with unexplained volume depletion, hypotension, hyponatremia, hyperkalemia, fever, abdominal pain, hyperpigmentation, or hypoglycemia (especially in children)【21】.

• Simultaneously measure plasma ACTH to differentiate primary from secondary causes【21】.

• A morning cortisol < 140 nmol/L (< 5 µg/dL) together with ACTH > 2 × the upper limit of normal is highly predictive of primary adrenal insufficiency【21】.

• In severe presentations, initiate intravenous hydrocortisone stress‑dose therapy immediately without awaiting laboratory results【21】.

5. Interpretation of Morning Cortisol for Glucocorticoid‑Induced Adrenal Insufficiency

(European Society of Endocrinology / Endocrine Society 2024 guidelines)

Note: Patients with cortisol values near 300 nmol/L may still have an inadequate stress response during major illness, surgery, or trauma; provide stress‑dose coverage when clinically indicated【19】.

6. Primary Adrenal Insufficiency Screening Thresholds

• Morning cortisol < 138‑140 nmol/L (< 5 µg/dL) strongly suggests adrenal insufficiency, especially when ACTH is elevated【21】.
• Intermediate values require dynamic ACTH (cosyntropin) stimulation testing for definitive diagnosis【21】.

7. Technical Requirements for Accurate Testing

• Timing: Collect blood between 8:00‑9:00 AM to capture the physiological peak【19】【20】.
• Washout: Hold glucocorticoid dose ≥24 h before sampling (longer for dexamethasone)【19】【20】.
• Medication Switch: Convert long‑acting glucocorticoids (dexamethasone, betamethasone) to shorter‑acting agents (hydrocortisone, prednisone) before testing【16】【17】【20】.

Conditions That May Produce Misleading Total Cortisol Results

8. Role of Dynamic (ACTH Stimulation) Testing

• Routine ACTH stimulation testing is not recommended for patients tapering or stopping glucocorticoids【16】【17】【18】.

• Limited Indications for ACTH stimulation:

• Standard Protocol: 250 µg synthetic ACTH (cosyntropin) administered IV or IM; cortisol measured at baseline and at 30 min (or 60 min). A peak cortisol > 500 nmol/L (> 18 µg/dL) indicates adequate adrenal reserve (assay‑specific cutoffs may vary)【21】.

9. Common Pitfalls to Avoid

• Testing too early during taper—wait until physiologic replacement doses are reached【16】【17】【18】.
• Ignoring assay variability—apply laboratory‑specific reference ranges (immunoassay cutoffs can vary widely).
• Over‑interpreting biochemical suppression—biochemical adrenal insufficiency after taper is common, but clinically significant adrenal crisis is rare【19】【20】.

10. Referral to Endocrinology

• Refer patients who fail to recover HPA axis function after ≥ 1 year on physiologic replacement doses【16】【17】【18】.
• Refer patients who experience adrenal crisis while on or after discontinuing glucocorticoids【19】.
• Refer patients with complex or atypical presentations that require specialized management【16】.

Guideline Summary for Interpreting Cosyntropin Stimulation Test Results

Diagnostic Thresholds for Adrenal Insufficiency

• A stimulated cortisol ≥ 18 µg/dL (≥ 500 nmol/L) at 30 or 60 minutes after cosyntropin reliably excludes adrenal insufficiency; the 60‑minute value of 19.2 µg/dL in this case exceeds that FDA‑approved cutoff. 22
• The Endocrine Society guideline recommends the same ≥ 18 µg/dL (≥ 500 nmol/L) threshold for confirming adequate adrenocortical reserve. 23

Optimal Timing of Cortisol Measurement

• The 60‑minute post‑cosyntropin cortisol measurement is the most reliable time point for diagnosing adrenal insufficiency, providing greater diagnostic certainty and reducing false‑positive results compared with the 30‑minute sample. 22, 23
• The Endocrine Society notes that cortisol levels are modestly higher at 60 minutes than at 30 minutes, and the 30‑minute value has been validated against the insulin‑tolerance test, but the 60‑minute value remains the preferred diagnostic marker. 22, 23

Evidence of Intact Adrenal Responsiveness

• A rise from baseline cortisol (~6 µg/dL) to a peak of 19.2 µg/dL demonstrates preserved adrenal responsiveness; a stimulated cortisol > 500 nmol/L (≈ 18 µg/dL) is accepted as evidence of sufficient adrenocortical function. 23

Clinical Decision‑Making for Primary Adrenal Insufficiency

• A peak cortisol > 18 µg/dL makes primary adrenal insufficiency highly unlikely, and no further dynamic testing is required. 22, 23
• If clinical suspicion persists despite a normal cosyntropin test, baseline plasma ACTH should be measured. Primary adrenal insufficiency is characterized by ACTH > 2 × the upper limit of normal (≈ 66 pmol/L or > 300 pg/mL) together with a low baseline cortisol (< 5 µg/dL). 22, 23
• Simultaneous measurement of baseline ACTH with baseline cortisol is essential to differentiate primary from secondary causes of adrenal insufficiency. 22, 23

Evaluation of Possible Secondary (Central) Adrenal Insufficiency

• When secondary adrenal insufficiency remains a concern despite a normal cosyntropin test, an insulin‑tolerance test or measurement of morning cortisol after glucocorticoid washout should be considered. 22

• The robust cortisol response observed (peak 19.2 µg/dL) makes clinically significant secondary adrenal insufficiency unlikely in this scenario. 22